Butterfly Network (NYSE:BFLY) shares climbed 17% on Thursday after Midjourney revealed a new medical imaging platform powered by Butterfly’s Ultrasound-on-Chip technology, highlighting a potentially significant new commercial application for the company’s semiconductor-based ultrasound platform.

Butterfly Network (NYSE: BFLY) soars 33% to a 52-week high after Midjourney Medical announces a full-body ultrasound scanner built with 40 Butterfly Ultrasound-on-Chip(TM) modules under a deal worth up to $74 million.

Butterfly Network Inc. BFLY stock is trading higher on Thursday after it commented on Midjourney's announcement of Midjourney Medical and the Midjourney Scanner, a full-body tomographic imaging system.

Shares of ultrasound device concern Butterfly Network, Inc. (BFLY) have doubled since announcing the launch of Compass AI, aimed at improving workflows on November 17, 2025. The company's novel approach to its handheld, single-probe, full-body ultrasound ...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced its inclusion in the first edition of ...